MLB names Spectrum Solutions as partner in league-wide COVID-19 testing program for 2020 season

By Major League Baseball
Published: August 13, 2020

MLB Utilizing Spectrum Saliva Collection Kits for Players and Club Staff

Major League Baseball has named Spectrum Solutions, LLC as a partner in its COVID-19 testing program for the 2020 season.

Spectrum is supplying MLB and its Clubs with its SDNA-1000 saliva collection kits for all player and staff testing. The non-invasive saliva collection device has become a critical component of MLB’s COVID-19 health monitoring and testing plan and is serving as one of the key interlocking safeguards to help maintain the health and safety of MLB personnel.

“We would like to thank Spectrum Solutions for playing such an integral role in Major League Baseball’s return to the field in 2020,” said Jon Coyles, MLB Vice President, Drug, Health, and Safety Programs. “We needed a safe, reliable, and non-invasive way to regularly test and monitor players and Club personnel this season. Spectrum has proven to be the best option available for our ongoing needs. We appreciate Spectrum’s support, collaboration, and assistance during this challenging time.”

“The entire team here at Spectrum loves Major League Baseball and we couldn’t be prouder to be part of the solution in helping the league with its key testing needs,” said Bill Phillips, COO of Spectrum Solutions. “Easy to use, pain-free saliva collection for COVID-19 testing is an essential part of MLB’s health and safety protocols. Spectrum is happy our SDNA-1000 kits are serving to support MLB play this 2020 season.”

About Spectrum Solutions and Spectrum DNA
Headquartered in Salt Lake City, Utah, Spectrum Solutions and its medical device and services division, Spectrum DNA, focus their concentrated industry expertise on engineering innovative end-to-end solutions for both clinical diagnostic projects and commercial product plans. A single-source provider of on-site medical device manufacturing, custom packaging, kitting, and direct-to-consumer fulfillment. Our biosample collection devices, patented technologies, and dedicated services easily deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability.

Spectrum Solutions and MLB-Brand Partnership

Contact: Michael Teevan or David Hochman, Major League Baseball,, @MLB_PR,
Tim Rush, Springboard5 for Spectrum Solutions,

WALL STREET JOURNAL: Actually, There Will Be Spitting in Baseball—When Players Are Tested

Spectrum in the News

Spectrum in the News

About the Product

Innovative Engineering SDNA-1000


Spectrum Solutions has manufactured over 20 million Saliva Collection devices for distribution worldwide. Spectrum’s technically superior  SDNA-1000 saliva collection device was engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications delivering the safest and most robust biomaterial collection approach for the detection and diagnosis of disease or viral infection.

  • First saliva collection device to receive EUA authorization for COVID-19 testing
  • First saliva collection device FDA authorized for at-home sample collection
  • Only pain-free biosample collection option for COVID-19 testing
  • Engineered to reduce self-collection error
  • Delivers consistent high-quality, high-yield biosamples
  • 100% inactivation of the live virus
  • 100% bacteriostatic
  • Delivers over a 90% reduction in PPE usage compared to current swab collections for COVID-19 testing
  • Single device preserves both DNA and fragile viral RNA transcripts
  • Device stabilizes and extends biosample viability post-collection over 10 days with no degradation of sample efficacy extending shipping and transport options
  • Saliva collection system mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
Questions? Let’s Connect